| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/25/2008 | US7348346 Use as antidiabetic agents, treating hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis; (3S, 5S)-4-([5-(Thiazolidine-3-carbonyl)-pyrrolidin-3-ylmethyl]-sulfamoyl)-benzoic acid for example |
| 03/25/2008 | US7348343 N-(N-heteroaryl)1-pyridyl- or -pyrimidyl-hydropyridine-4-carboxamides; e.g., 3'-Chloro-3,6-dihydro-2H-[1,2']bipyridinyl-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide and 1-pyrimidin-2-yl-1,2,3,6-tetrahydro-pyridine-4-carboxylic acid (6-trifluoromethyl-pyridin-3-yl)-amide |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348340 "caused" by the stimulation of nociceptive receptors and transmitted over intact neural pathways; 2-(4-Chlorophenyl)-quinoline-4,6-diamine; acute, persistent and neuropathic pain |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348337 heterocyclic oxo amides such as 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione, used as viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | CA2288322C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/25/2008 | CA2250002C Cephem compounds and drugs containing the compounds |
| 03/25/2008 | CA2173493C Fused pyridazine compounds |
| 03/20/2008 | WO2008033931A1 Para-xylylene carboxylic acids and isothiazolones useful as protein tyrosine phosphatases (ptps) in particular ptp-ib |
| 03/20/2008 | WO2008033854A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | WO2008033834A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/20/2008 | WO2008033764A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 03/20/2008 | WO2008033567A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/20/2008 | WO2008033465A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | WO2008033455A2 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors |
| 03/20/2008 | WO2008032330A2 Improved process for rimonabant |
| 03/20/2008 | WO2008032204A1 Substituted pyridylmethyl bicyclocarboxyamide compounds |
| 03/20/2008 | WO2008032136A1 An improved process for the preparation of desloratadine |
| 03/20/2008 | WO2008032091A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032089A1 4-benzimidaz0lyl-2-m0rph0lin0-6-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032086A1 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032072A1 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032060A1 4-benzimidaz0lyl-6-m0rph0lin0-2-piperazinylpyrimidine derivatives as p13k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032041A1 Pyrimidine derivatives having inhibitory activity against pi3k enzymes |
| 03/20/2008 | WO2008032036A1 6-benzimidaz0lyl-2-m0rph0lin0-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032033A1 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032028A1 2 -benzimidazolyl- 6 -morpholino-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008031735A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 03/20/2008 | WO2008031734A1 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | WO2008031556A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 03/20/2008 | WO2008031549A1 Process for the preparation of anthranilamide derivatives |
| 03/20/2008 | WO2008031548A1 Process for the preparation of anthranilamide derivatives |
| 03/20/2008 | WO2008031227A1 Diaryl piperidine compounds as calcium channel blockers |
| 03/20/2008 | WO2008017466A8 Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| 03/20/2008 | WO2008014247A3 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 03/20/2008 | WO2008009750A3 Macrocyclic compounds useful as bace inhibitors |
| 03/20/2008 | WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 03/20/2008 | WO2007146341A9 Amorphous and crystalline forms of pantoprazole magnesium salt |
| 03/20/2008 | WO2007144769A3 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/20/2008 | WO2007144512A3 Diazeniumdiolate derivatives, method for the preparation thereof, pharmaceutical compositions thereof, and use of same in the fields of hypertension and cardiovascular pathologies |
| 03/20/2008 | WO2007140174A3 Compounds and methods for modulating fxr |
| 03/20/2008 | WO2007136510A3 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha |
| 03/20/2008 | WO2007133983A3 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/20/2008 | WO2007113327A3 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 03/20/2008 | WO2007080131A3 Anthranilamide derivatives and their use for the control of insects and acari |
| 03/20/2008 | WO2007072092A8 New phenanthridine derivatives as bradykinin antagonists |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080071089 Reacting rabeprazole with aqueous sodium hydroxide; salt formation; adding ethanol; agitation in nonsolvent; isolation |
| 03/20/2008 | US20080071088 Drugs for respiratory system disorders; also chemical intermediate for such drugs |
| 03/20/2008 | US20080070949 Polymorphs of rimonabant |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070945 4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-2-thione as specific alpha2b agonist and methods of using the same |
| 03/20/2008 | US20080070935 Isoquinoline, Quinazoline and Phthalazine Derivatives |
| 03/20/2008 | US20080070931 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070915 Poly(ADP-ribose)polymerase (PARP); ischemia, reperfusion injuries, neurological disorders, neuroprotectants, sensitizer for chemotherapy or radiotherapy, anticancer |
| 03/20/2008 | US20080070913 Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors |
| 03/20/2008 | US20080070912 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070903 New pyrimidine derivatives and new pyridine derivatives |
| 03/20/2008 | US20080070902 Cinnamide Compound |
| 03/20/2008 | US20080070899 (Calcitonin gene related peptide); headache, migraine and cluster headache; spiropiperidine-substituted azepan-2-ones such as 1-(2,2,2-trifluoroethyl)-3-(1-oxo-2,8-diazaspiro[4.5]decan-8-yl-aminocarbonylamino)6-(2,3-difluorophenyl)azepan-2-one |
| 03/20/2008 | US20080070898 Sodium channel inhibitor of low side effect; analgesics; neuropathic pain; 4-(2-{4-[(E)-2-(2-methylphenyl)vinyl]piperidin-1-yl}-2-oxoethyl)morpholine for example |
| 03/20/2008 | US20080070895 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 03/20/2008 | US20080070093 aromatic resins having heat and oxidation resistance, high doping ability and high conductivity values, used as electrolytes in high temperature proton exchange-membrane fuel cells |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | DE102007037830A1 Indolinsulfonamidverbindungen Indolinsulfonamidverbindungen |
| 03/20/2008 | DE102006040915A1 New oxindole derivatives useful for treating vasopressin- or oxytocin-dependent diseases |
| 03/20/2008 | CA2663503A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | CA2663376A1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/20/2008 | CA2663280A1 Diaryl piperidine compounds as calcium channel blockers |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2662902A1 Kinase inhibitor compounds |
| 03/20/2008 | CA2662409A1 5-phenyl-nicotinamide derivatives |
| 03/20/2008 | CA2662099A1 Pyridine- and quinoline-pyrimidine-derivatives |
| 03/20/2008 | CA2661951A1 Substituted amides, method of making, and method of use thereof |
| 03/20/2008 | CA2661938A1 Pyrimidines derivatives and their use as kinase inhibitors |
| 03/20/2008 | CA2661654A1 Certain substituted amides, method of making, and method of use thereof |
| 03/19/2008 | EP1900735A1 Pyridazinyl amine derivatives, the use thereof in the preparation of picorna virus inhibitors |
| 03/19/2008 | EP1900733A1 Process for production of 4(3h)-quinazolinone derivative |
| 03/19/2008 | EP1900732A1 Novel nitrogenated heterocyclic compound and salt thereof |
| 03/19/2008 | EP1900731A1 N-(1-Phthalazin-1-yl-piperidin-4-yl)-amides as EP2-receptor modulators |
| 03/19/2008 | EP1900730A1 Process for the preparation of anthranilamide derivatives |
| 03/19/2008 | EP1900727A1 Aminopyridine derivatives as kinase inhibitors |
| 03/19/2008 | EP1900726A1 Heterocyclic thioesters |
| 03/19/2008 | EP1900721A1 Substituted cyclic compound, its preparation process and its medical use |
| 03/19/2008 | EP1899329A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |